These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34453788)

  • 1. Vascular endothelial growth factor profile and Vitamin D level in Systemic Sclerosis Egyptian patients.
    El Gharbawy NH; Sheha DS; Bawady SA; El Leithy SA
    Egypt J Immunol; 2021 Jul; 28(3):168-175. PubMed ID: 34453788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated vascular endothelial growth factor in systemic sclerosis.
    Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
    J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
    Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
    Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D and Cytokine Profiles in Patients With Systemic Sclerosis.
    Hax V; Gasparin AA; Schneider L; Monticielo OA; Soares HMF; Streit MDA; Pfaffenseller B; Xavier RM; Chakr RMDS
    J Clin Rheumatol; 2020 Oct; 26(7):289-294. PubMed ID: 31397760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low vitamin D serum levels in diffuse systemic sclerosis: a correlation with worst quality of life and severe capillaroscopic findings.
    Sampaio-Barros MM; Takayama L; Sampaio-Barros PD; Bonfá E; Pereira RM
    Rev Bras Reumatol Engl Ed; 2016; 56(4):337-44. PubMed ID: 27476627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of angiogenic homeostasis in systemic sclerosis.
    Farouk HM; Hamza SH; El Bakry SA; Youssef SS; Aly IM; Moustafa AA; Assaf NY; El Dakrony AH
    Int J Rheum Dis; 2013 Aug; 16(4):448-54. PubMed ID: 23992267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalanced serum levels of Ang1, Ang2 and VEGF in systemic sclerosis: Integrated effects on microvascular reactivity.
    Michalska-Jakubus M; Cutolo M; Smith V; Krasowska D
    Microvasc Res; 2019 Sep; 125():103881. PubMed ID: 31075243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
    Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
    Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature.
    Arnson Y; Amital H; Agmon-Levin N; Alon D; Sánchez-Castañón M; López-Hoyos M; Matucci-Cerinic M; Szücs G; Shapira Y; Szekanecz Z; Shoenfeld Y
    Autoimmun Rev; 2011 Jun; 10(8):490-4. PubMed ID: 21320645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor in systemic lupus erythematosus: relationship to disease activity, systemic organ manifestation, and nailfold capillaroscopic abnormalities.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S; Ciołkiewicz M
    Arch Immunol Ther Exp (Warsz); 2007; 55(3):179-85. PubMed ID: 17557150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth Differentiation Factor-15 (GDF-15) Level and Relation to Clinical Manifestations in Egyptian Systemic Sclerosis patients: Preliminary Data.
    Gamal SM; Elgengehy FT; Kamal A; El Bakry SA; Shabaan E; Elgendy A; Bassyouni IH
    Immunol Invest; 2017 Oct; 46(7):703-713. PubMed ID: 28872977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients.
    Ruaro B; Pizzorni C; Paolino S; Smith V; Ghio M; Casabella A; Alessandri E; Patané M; Sulli A; Cutolo M
    Microvasc Res; 2019 Sep; 125():103874. PubMed ID: 30974112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nailfold capillaroscopy by digital microscope in an Indian population with systemic sclerosis.
    Bhakuni DS; Vasdev V; Garg MK; Narayanan K; Jain R; Mullick G
    Int J Rheum Dis; 2012 Feb; 15(1):95-101. PubMed ID: 22324952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase angle could be a marker of microvascular damage in systemic sclerosis.
    Gigante A; Gasperini ML; Rosato E; Navarini L; Margiotta D; Afeltra A; Muscaritoli M
    Nutrition; 2020 May; 73():110730. PubMed ID: 32179402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.
    Corrado A; Colia R; Mele A; Di Bello V; Trotta A; Neve A; Cantatore FP
    PLoS One; 2015; 10(9):e0137912. PubMed ID: 26375284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin fibrosis correlates with circulating thyrotropin levels in systemic sclerosis: translational association with Hashimoto's thyroiditis.
    Bagnato GL; Roberts WN; Fiorenza A; Arcuri C; Certo R; Trimarchi F; Ruggeri RM; Bagnato GF
    Endocrine; 2016 Feb; 51(2):291-7. PubMed ID: 25994300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis--association with pulmonary involvement.
    Dziankowska-Bartkowiak B; Waszczykowska E; Dziankowska-Zaboroszczyk E; de Graft-Johnson JE; Zalewska A; Łuczyńska M; Nowak D
    Clin Exp Rheumatol; 2006; 24(5):508-13. PubMed ID: 17181918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
    Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V;
    Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered serum level of metabolic and endothelial factors in patients with systemic sclerosis.
    Stochmal A; Czuwara J; Zaremba M; Rudnicka L
    Arch Dermatol Res; 2020 Aug; 312(6):453-458. PubMed ID: 31667578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Lymphangiogenic Factors With Pulmonary Arterial Hypertension in Systemic Sclerosis.
    Didriksen H; Molberg Ø; Fretheim H; Gude E; Jordan S; Brunborg C; Palchevskiy V; Garen T; Midtvedt Ø; Andreassen AK; Distler O; Belperio J; Hoffmann-Vold AM
    Arthritis Rheumatol; 2021 Jul; 73(7):1277-1287. PubMed ID: 33497027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.